These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15746908)

  • 41. Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury.
    Wu ZY; Hui GZ; Lu Y; Wu X; Guo LH
    Chin Med J (Engl); 2006 Dec; 119(24):2101-7. PubMed ID: 17199962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice.
    Koda M; Nishio Y; Kamada T; Someya Y; Okawa A; Mori C; Yoshinaga K; Okada S; Moriya H; Yamazaki M
    Brain Res; 2007 May; 1149():223-31. PubMed ID: 17391650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Stem cells and neural repair].
    Privat A
    Bull Acad Natl Med; 2005 Apr; 189(4):605-13; discussion 613-4. PubMed ID: 16245679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficient differentiation and integration of lineage-restricted neural precursors in the traumatically injured adult cat spinal cord.
    Alexanian AR; Crowe MJ; Kurpad SN
    J Neurosci Methods; 2006 Jan; 150(1):41-6. PubMed ID: 16087243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery.
    Hicks AU; Lappalainen RS; Narkilahti S; Suuronen R; Corbett D; Sivenius J; Hovatta O; Jolkkonen J
    Eur J Neurosci; 2009 Feb; 29(3):562-74. PubMed ID: 19175403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF.
    Hayashi K; Ohta S; Kawakami Y; Toda M
    Neurosci Res; 2009 May; 64(1):96-103. PubMed ID: 19428687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.
    Abrams MB; Dominguez C; Pernold K; Reger R; Wiesenfeld-Hallin Z; Olson L; Prockop D
    Restor Neurol Neurosci; 2009; 27(4):307-21. PubMed ID: 19738324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem and progenitor cell therapies: recent progress for spinal cord injury repair.
    Louro J; Pearse DD
    Neurol Res; 2008 Feb; 30(1):5-16. PubMed ID: 18387258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem cell based growth factory delivery to the injured spinal cord.
    Hofstetter CP; Boockvar JA
    Neurosurgery; 2010 Feb; 66(2):N16-7. PubMed ID: 20087121
    [No Abstract]   [Full Text] [Related]  

  • 50. Targeting ependymal stem cells in vivo as a non-invasive therapy for spinal cord injury.
    Barreiro-Iglesias A
    Dis Model Mech; 2010; 3(11-12):667-8. PubMed ID: 20959637
    [No Abstract]   [Full Text] [Related]  

  • 51. Pain in individuals who suffered a spinal cord injury. How does pain interfere. Hope for improved management.
    Wyndaele JJ
    Spinal Cord; 2009 May; 47(5):351. PubMed ID: 19421196
    [No Abstract]   [Full Text] [Related]  

  • 52. Transcutaneous nerve stimulation for treatment of pain in spinal-cord-injured patients.
    Davis R; Lentini R
    Bull Prosthet Res; 1974; ():298-301. PubMed ID: 4462912
    [No Abstract]   [Full Text] [Related]  

  • 53. Can cell therapy heal a spinal cord injury?
    Ronsyn MW; Berneman ZN; Van Tendeloo VF; Jorens PG; Ponsaerts P
    Spinal Cord; 2008 Aug; 46(8):532-9. PubMed ID: 18347607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The stem cell journey: from paradise to purgatory.
    Bordey A
    Neuropharmacology; 2010 May; 58(6):833-4. PubMed ID: 20146927
    [No Abstract]   [Full Text] [Related]  

  • 55. Traumatic central cord syndrome.
    Wyndaele JJ
    Spinal Cord; 2010 Sep; 48(9):651. PubMed ID: 20811391
    [No Abstract]   [Full Text] [Related]  

  • 56. Deafferentation pain after spinal cord injury. Part II. Management.
    Segatore M
    SCI Nurs; 1992 Aug; 9(3):72-8. PubMed ID: 1519040
    [No Abstract]   [Full Text] [Related]  

  • 57. Guest editorial: promoting optimal function after spinal cord injury.
    Field-Fote E
    J Neurol Phys Ther; 2005 Jun; 29(2):54. PubMed ID: 16386162
    [No Abstract]   [Full Text] [Related]  

  • 58. Commentary: Preclinical Validation of Multilevel Intraparenchymal Stem Cell Therapy in the Porcine Spinal Cord.
    Nagoshi N; Nakashima H; Fehlings MG
    Neurosurgery; 2016 Feb; 78(2):E309. PubMed ID: 26540358
    [No Abstract]   [Full Text] [Related]  

  • 59. The challenges of translating stem cells for spinal cord injury and related disorders: what are the barriers and opportunities?
    Hewson SM; Fehlings LN; Messih M; Fehlings MG
    Expert Rev Neurother; 2013 Feb; 13(2):143-50. PubMed ID: 23368801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The acute management of associated injuries in the spinal cord injured patient.
    Proc Veterans Adm Spinal Cord Inj Conf; 1973 Oct 29-31; (19):196-201. PubMed ID: 4499941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.